Research programme: psoriatic arthritis - deCODE geneticsAlternative Names: Psoriatic arthritis research programme - deCODE genetics
Latest Information Update: 15 Sep 2006
At a glance
- Originator deCODE genetics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Psoriatic arthritis
Most Recent Events
- 05 Feb 2003 Preclinical trials in Psoriatic arthritis in Iceland (unspecified route)